Search Results - "Marsolais, C"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV by Adrian, S, Scherzinger, A, Sanyal, A, Lake, J E, Falutz, J, Dubé, M P, Stanley, T, Grinspoon, S, Mamputu, J-C, Marsolais, C, Brown, T T, Erlandson, K M

    Published in The Journal of frailty & aging (2019)
    “…Tesamorelin, a growth hormone-releasing hormone analogue, decreases visceral adipose tissue in people living with HIV, however, the effects on skeletal muscle…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Activity of (−)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units by Siu, L. L., Attardo, G., Izbicka, E., Lawrence, R., Cerna, C., Gomez, L., Davidson, K., Finkle, C., Marsolais, C., Rowinsky, E. K., von Hoff, D. D.

    Published in Annals of oncology (01-08-1998)
    “…Background: BCH-4556 ((−)-2'-deoxy-3'-oxacytidine) is an L-nucleoside analogue shown to have broad preclinical anti-cancer activity, particularly against solid…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Reduction in Visceral Adiposity Is Associated With an Improved Metabolic Profile in HIV-Infected Patients Receiving Tesamorelin by Stanley, Takara L., Falutz, Julian, Marsolais, Christian, Morin, Josée, Soulban, Graziella, Mamputu, Jean-Claude, Assaad, Hani, Turner, Ralph, Grinspoon, Steven K.

    Published in Clinical infectious diseases (01-06-2012)
    “…Background. Tesamorelin, a growth hormone—releasing hormone analogue, decreases visceral adipose tissue (VAT) by 15%—20% over 6—12 months in individuals with…”
    Get full text
    Journal Article
  8. 8

    Évaluation des profils génotypiques associés à la sensibilité du VIH-1 à l’ibalizumab by Jullien, H., Leonard, M., Cash, B., Mesquita, P., Weinheimer, S., Marsolais, C.

    Published in Infectious diseases now (Online) (01-08-2021)
    “…Ibalizumab (IBA) cible le domaine 2 du récepteur CD4. Il est indiqué, associé à d’autres ARV dans le traitement des adultes infectés par le VIH-1…”
    Get full text
    Journal Article
  9. 9

    Compartmentation of 14CO2 in the perfused rat liver by Marsolais, C., Huot, S., David, F., Garneau, M., Brunengraber, H.

    Published in The Journal of biological chemistry (25-02-1987)
    “…The specific activity of the mitochondrial CO2 + bicarbonate system has been measured in perfused livers using the specific activities of urea and acetoacetate…”
    Get full text
    Journal Article
  10. 10

    Reassessment of 14CO2 compartmentation and of [14C]formate oxidation in rat liver by MARSOLAIS, C, LAFRENIERE, F, DAVID, F, DODGSON, S. J, BRUNENGRABER, H

    Published in The Journal of biological chemistry (25-11-1989)
    “…Our previous report (Marsolais, C., Huot, S., David, F., Garneau, M., and Brunengraber, H. (1987) J. Biol. Chem. 262, 2604-2607) had concluded that a fraction…”
    Get full text
    Journal Article
  11. 11

    Reassessment of sup 14 CO sub 2 compartmentation and of ( sup 14 C)formate oxidation in rat liver by Marsolais, C., Lafreniere, F., David, F., Dodgson, S.J., Brunengraber, H.

    Published in The Journal of biological chemistry (25-11-1989)
    “…Our previous report had concluded that a fraction of ({sup 14}C)formate oxidation in liver occurs in the mitochondrion. This conclusion was based on the…”
    Get full text
    Journal Article
  12. 12